Skip to Main Content

Author Details

Ralph S Baric
University of North Carolina
1981
569
122
PMIDPaper TitleJournal TitlePublished Year
38036767BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.Nat Immunol2024
38036767BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.Nat Immunol2024
38016504A nano-luciferase expressing human coronavirus OC43 for countermeasure development.Virus Res2024
37781879A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.J Infect Dis2024
38016504A nano-luciferase expressing human coronavirus OC43 for countermeasure development.Virus Res2024
37781879A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.J Infect Dis2024
36454813Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.Sci Transl Med2023
38036525Engineered immunogens to elicit antibodies against conserved coronavirus epitopes.Nat Commun2023
37756379A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus.Sci Transl Med2023
37749254Host range, transmissibility and antigenicity of a pangolin coronavirus.Nat Microbiol2023
37662930Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters.Front Immunol2023
37596064Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?FEMS Microbiol Rev2023
38019013Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.J Virol2023
37662274<i>N</i><sup>4</sup> -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness.bioRxiv2023
37909048Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.Cell Host Microbe2023
37725085Evolution of a functionally intact but antigenically distinct DENV fusion loop.Elife2023
37800919Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2.mBio2023
37796612Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine.JCI Insight2023
37794071Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera.Nat Commun2023
37634194Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals.J Proteome Res2023
37961507Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.Res Sq2023
36909627Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes.bioRxiv2023
36711543Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.bioRxiv2023
37398270A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels.bioRxiv2023
37205380Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection.Res Sq2023
36763096Coronavirus Immunotherapeutic Consortium Database.Database (Oxford)2023
37012355Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2.Nat Microbiol2023
36812267Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements.PLoS Pathog2023
36565697Clonal replacement sustains long-lived germinal centers primed by respiratory viruses.Cell2023
37193127Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East respiratory syndrome coronavirus infection.iScience2023
36870874A research and development (R&amp;D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy.Vaccine2023
37066219Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake.medRxiv2023
37000623Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.Cell Rep2023
36993423Mouse Adapted SARS-CoV-2 Model Induces "Long-COVID" Neuropathology in BALB/c Mice.bioRxiv2023
37425890Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential.bioRxiv2023
36854303Emergent variant modeling of the serological repertoire to norovirus in young children.Cell Rep Med2023
37293083Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice.bioRxiv2023
37163615Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.Sci Transl Med2023
370404391-<i>O</i>-Octadecyl-2-<i>O</i>-benzyl-<i>sn</i>-glyceryl-3-<i>phospho</i>-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity.J Med Chem2023
36851745Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron.Viruses2023
36454813Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.Sci Transl Med2023
37546738Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.bioRxiv2023
37034784Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop.bioRxiv2023
36914616A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.Nat Commun2023
37634194Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals.J Proteome Res2023
38019013Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.J Virol2023
37756379A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus.Sci Transl Med2023
37596064Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?FEMS Microbiol Rev2023
37961507Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.Res Sq2023
37909048Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.Cell Host Microbe2023
  • 1 - 50 of 1,138

Recommended Authors

University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year 2017
Number of shared co-authors 4
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 9
Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 10
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 7
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 2
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 6
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 23
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 8
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 6
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 8
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 13
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 2
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 1
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 9
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 19
University of Iowa
Career Start Year 2002
Number of shared co-authors 18
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 4
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2001
Number of shared co-authors 13
University of California riverside
Career Start Year 1999
Number of shared co-authors 10
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 21
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 35
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 22
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 14
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 20
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 13
University College London
Career Start Year 1992
Number of shared co-authors 8
College of Veterinary Medicine, Kansas State University
Career Start Year 1988
Number of shared co-authors 17
University of California san francisco
Career Start Year 1981
Number of shared co-authors 17
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 14

Collaborators

University of North Carolina at Chapel Hill
Co-authored papers 112
University of North Carolina at Chapel Hill
Co-authored papers 68
University of North Carolina at Chapel Hill
Co-authored papers 68
University of North Carolina at Chapel Hill
Co-authored papers 66
The University of North Carolina at Chapel Hill
Co-authored papers 59
University of North Carolina
Co-authored papers 56
Co-authored papers 54
University of North Carolina at Chapel Hill.
Co-authored papers 52
University of Texas Medical Branch
Co-authored papers 40
Vanderbilt University Medical Center
Co-authored papers 33
University of North Carolina.
Co-authored papers 32
National Center for Toxicological Research
Co-authored papers 26
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 25
University of Washington
Co-authored papers 22
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers 22
University of North Carolina at Chapel Hill
Co-authored papers 21
Influenza Research Institute, University of Wisconsin
Co-authored papers 20
University of North Carolina
Co-authored papers 19
Co-authored papers 19
Pacific Northwest National Laboratory
Co-authored papers 19
Marsico Lung Institute, University of North Carolina-Chapel Hill
Co-authored papers 18
Co-authored papers 18
Washington University School of Medicine
Co-authored papers 15
Co-authored papers 15
Oregon Health & Science University, University of California Berkeley
Co-authored papers 15
Co-authored papers 14
Vanderbilt University Medical Center
Co-authored papers 14
Co-authored papers 14
Co-authored papers 14
University of North Carolina at Chapel Hill
Co-authored papers 14